Flex and Merck KGaA, Darmstadt, Germany, Win 2025 PDA Drug Delivery Innovation Award

Rhea-AI Summary

Flex (NASDAQ: FLEX) said its Health Solutions business won the 2025 PDA Drug Delivery Innovation Award on Nov 13, 2025 for a collaboration with Merck KGaA, Darmstadt, Germany, on a connected autoinjector.

The entry, presented at the PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Vienna, recognized a connected autoinjector ecosystem that includes a smart device, cloud data system, patient mobile app, and clinician dashboard to support adherence and personalized care.

News Market Reaction – FLEX

-5.39%

-5.39% Session close to close

In the Nov 13 session, FLEX declined 5.39%, reflecting a notable negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

AUSTIN, Texas, Nov. 13, 2025/PRNewswire/ -- Flex (NASDAQ: FLEX) today announced that its Health Solutions business was awarded the prestigious 2025 PDA Drug Delivery Innovation Award for its collaboration with Merck KGaA, Darmstadt, Germany, on their connected autoinjector.

The award, presented at the 2025 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Vienna, Austria, recognized the collaboration of Flex and Merck KGaA, Darmstadt, Germany, to supporting patient outcomes through digital health solutions. The winning entry, "Empowering Patients: The Benefits of Connected Injection Devices on Health Outcomes – A Focus on Autoinjectors," highlights the impact and benefits of an integrated digital ecosystem in chronic disease management.

Flex has collaborated with Merck KGaA, Darmstadt, Germany, for nearly two decades to develop patient-centric drug delivery solutions focused on improving therapy adherence, patient experience, and healthcare provider decision-making. This award underscores Flex's ability to pair user-centric product design with global manufacturing scale and reflects the dedication of Merck KGaA, Darmstadt, Germany, to strive to positively impact millions of lives every day.

The connected autoinjector solution integrates a smart injection device, a cloud-based data system, a mobile app for patients, and a monitoring dashboard for healthcare professionals. With automated injection, real-time data sharing, personalized settings, and intuitive interfaces, it enables both patients and providers to enhance treatment efficiency and outcomes.

"We are honored to receive the PDA Drug Delivery Innovation Award alongside our partners at Merck KGaA, Darmstadt, Germany," said Riccardo Butta, president of the Health Solutions business at Flex. "This recognition reflects our shared commitment to patient-centric design, digital innovation, and advanced manufacturing excellence. Together, we aim to provide solutions that are focused on supporting patient adherence, facilitating personalized care, and contributing to improved health outcomes."

Flex's collaboration with Merck KGaA, Darmstadt, Germany, exemplifies the power of long-term collaboration and technical excellence in delivering meaningful innovation within the healthcare industry. For more information about Flex's drug delivery capabilities, please visit: https://flex.com/industries/healthcare#drug-delivery

About Flex

Flex (Reg. No. 199002645H) is the manufacturing partner of choice that helps leading brands design, build, and manage products that improve the world. With a global footprint spanning 30 countries, Flex delivers advanced manufacturing and supply chain solutions, innovative products and technology, and lifecycle services that support customers from concept to scale. In the AI era, Flex is helping customers accelerate data center deployment by solving power, heat, and scale challenges through cutting-edge power and cooling technology and scalable IT infrastructure solutions.

Media Contact:

Conor Phillips
Director of Communication EMEA
+353 86 3851677
Conor.Phillips@flex.com

Investors & Analysts:

Michelle Simmons
Senior Vice President, Global Investor Relations and Public Relations
(669) 242-6332
Michelle.Simmons@flex.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/flex-and-merck-kgaa-darmstadt-germany-win-2025-pda-drug-delivery-innovation-award-302613760.html

SOURCE Flex

FAQ

What award did Flex (FLEX) win on November 13, 2025?

Flex won the 2025 PDA Drug Delivery Innovation Award for its connected autoinjector collaboration with Merck KGaA.

What features does the connected autoinjector from Flex and Merck KGaA include?

The solution integrates a smart injection device, cloud-based data, a patient mobile app, and a clinician monitoring dashboard.

Where and when was the PDA award presented to Flex (FLEX)?

The award was presented at the 2025 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Vienna, Austria.

How long have Flex and Merck KGaA collaborated on drug delivery solutions?

Flex and Merck KGaA have collaborated for nearly two decades on patient-centric drug delivery.

What investor-relevant claim did Flex emphasize about the award win?

Flex highlighted its ability to combine user-centric design with global manufacturing scale in health solutions.

Where can investors find more information about Flex drug delivery capabilities?

Investors can visit Flex's drug delivery page at https://flex.com/industries/healthcare#drug-delivery.